Konrad H. Stopsack
Research Scientists

Konrad H. Stopsack

Research Scientist




I am a molecular and clinical epidemiologist with a focus on cancer epidemiology and a background as a board-certified internal medicine physician. My main research interest is how potentially modifiable exposures cause solid tumors through genomic heterogeneity and influence cancer progression. I am passionate about combining well-defined observational studies and state-of-the-art genomics in order to guide cancer prevention and treatment. My methodologic and teaching interests include application and further development of epidemiologic methods for high-dimensional biomarker studies and clinical studies.

MD, 2013, Medicine
University of Freiburg, Freiburg, Germany

MPH, 2014, Biostatistics and Epidemiology
Harvard School of Public Health, Boston, MA

Residency, Board certification, 2017, Internal Medicine
Mayo Clinic, Rochester, MN

Postdoctoral training, 2021, Cancer Epidemiology
Memorial Sloan Kettering Cancer Center, New York, NY


Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research.

Hurwitz LM, Agalliu I, Albanes D, Barry KH, Berndt SI, Cai Q, Chen C, Cheng I, Genkinger JM, Giles GG, Huang J, Joshu CE, Key TJ, Knutsen S, Koutros S, Langseth H, Li SX, MacInnis RJ, Markt SC, Penney KL, Perez-Cornago A, Rohan TE, Smith-Warner SA, Stampfer MJ, Stopsack KH, Tangen CM, Travis RC, Weinstein SJ, Lang PhD W, Jacobs EJ, Mucci LA, Platz EA, Cook MB.

J Natl Cancer Inst. 2021 06 01. 113(6):727-734. PMID: 33010161